EUVIMED · CrossrefJournal
Molecular Therapy Methods & Clinical Development
ISSN 2329-0501 · Elsevier BV
Latest articles
Functional, sustained recovery of hearing in Otoferlin-deficient mice using DB-OTO, a hair-cell-specific AAV-based gene therapy
Morphological changes induced by buffer exchange during preparation of mRNA-lipid nanoparticles occur in a stepwise manner as pH is elevated
Comparative analysis of cell-specific promoters in AAV9-mediated gene therapy targeting the central nervous system
Biodistribution of AAV1, AAV5, AAV9, and AAVDJ serotypes after intra-cisterna magna delivery in non-human primates
A novel gene delivery platform based on a commensal human anellovirus demonstrates transduction in multiple tissue types
Heavy-chain immunoglobulin locus editing in rhesus macaque B cells to confer antibody production
Systemic mRNA-LNP administration in fetuses improves survival in a mouse model of spinal muscular atrophy
Efficient kidney gene transfer and proximal tubule transduction using self-complementary AAV.cc47 vectors
Adeno-associated virus serotype 9 structural heterogeneity and stability characterized by charge detection mass spectrometry
From cold chain to ambient: Benefits, risks, and evidence across cell therapy logistics
Targeted inhibition of ELANE expression using adenine base editing to treat severe congenital neutropenia
AAV-PHP.eB achieves superior neuronal transduction over AAV9 in pigtail macaques following intracerebroventricular administration
Toward CAR-B cells for HIV-1 therapy
AAV2 delivery of the saCas9 gene results in presentation of an HLA-A∗02:01-restricted T cell epitope potent to induce T cell cytotoxicity
Rational design of lipid nanoparticles for enabling gene therapies
Nonclinical strategies and considerations to enable the redosing of gene therapies
AAV8-based gene replacement therapy for hereditary spastic paraplegia type 5
AAV6 vectors provide superior gene transfer compared to AAV9 vectors following intramyocardial administration
Engineering chimeric PCSK9 for a vaccine against atherosclerosis
Rapid cochlear gene therapy in adult deaf mice: Vglut3 rescue via AAV8 achieves day-1 hearing restoration
Development of VNX-101, an adeno-associated virus with less immunogenicity and efficient long-term expression of a CD19 T cell engager
Enhanced B cell electroporation efficiency via inhibition of DNA-induced apoptosis and pyroptosis with pan-caspase inhibitor
FAP-CAR-T cells reduce dystrophic muscle fibrosis, improving adeno-associated virus gene transfer efficacy
Perineural delivery of AAV2/9 in non-human primates is a safe and efficient route for gene therapy in Charcot-Marie-Tooth diseases
Beneficial effect of resveratrol on T cell oxidative metabolism and anti-tumor function is conditioned by prior in vivo T cell history
Improved AAV9-based gene therapy design for SURF1-related Leigh syndrome with minimal toxicity
Development and implementation of an LC-MS-based multi-attribute method for adeno-associated virus
Harnessing mRNA-lipid nanoparticles as innovative therapies for autoimmune diseases
Natural history of preexisting AAV5 antibodies in adults with hemophilia B during the lead-in of the etranacogene dezaparvovec phase 3 study
A two-pass anion-exchange chromatography strategy for enrichment of full capsids in manufacturing of adeno-associated viral vectors
EUVIMED